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INTRODUCTION
Volumetric modulated arc therapy (VMAT) is a new radiotherapy technique which allows to achieve treatment plans of similar or improved quality compared to fixed-field intensitymodulated radiation therapy (IMRT) while reducing the treatment time per fraction [1] . In practice, to obtain highly modulated dose distributions delivered efficiently, a treatment planning system (TPS) with a powerful optimization and segmentation algorithm is required.
While a lot of users are in the process of replacing fixed-field IMRT by VMAT, or directly implementing VMAT in their radiotherapy department, there is a lack of information concerning the relative performances of the mainly used TPS for VMAT planning. To our knowledge, only three studies deal with this topic [2] [3] [4] . In Rao were compared to ERGO++ and Oncentra (Nucletron-Elekta) [3] . Finally, in Wiezorek et al, VMAT plans obtained with Monaco and Eclipse (Varian Medical System, Palo Alto, CA) were evaluated [4] . In these studies, the comparisons were made by fixing common planning objectives on PTVs and OARs and comparing the dosimetric results and treatment delivery efficiency (number of monitor units and treatment time).
The aim of the present study was to investigate the performances of two TPS that have not been compared yet in VMAT mode, both using different approaches for VMAT plan optimization:
Monaco based on a two-stage constrained optimization [5] and Pinnacle SmartArc [6] . This work was performed by two institutions. The aim was to compare VMAT plans performed by Monaco and Pinnacle regarding to dosimetric performances and treatment delivery specificities. We therefore fully put in evidence the differences observed in terms of dose distributions, delivery efficiency, treatment delivery parameters (mean dose rate, mean segment area) and quality control results on 10 prostate cancer cases.
MATERIALS AND METHODS

Patients
Ten prostate adenocarcinoma patients referred to our institutions for a radical external beam irradiation to the prostate and seminal vesicles (SV) were considered for this dosimetric comparative analysis.
Anatomic data acquisition, volumes definition and dose
Organs at risk [rectal wall (5 mm thickness), bladder wall (7 mm thickness), femoral heads (FH)]
and target volumes (prostate, SV) were delineated on dedicated 2 mm-thick CT slices.
The first clinical target volume (CTV1) comprised the prostate and SV. The CTV2 was limited to the prostate only. Planning target volumes (PTVs) were automatically generated adding a 3D 1 cm uniform margin around the CTVs, except in the posterior direction, where a 0.5 cm margin was added to protect the rectum.
The total prescription dose was 46 Gy to the PTV1 and an additional 32 Gy to the PTV2 using a standard fractionation (2 Gy per fraction, 5 days a week) for a total dose of 78 Gy using a sequential technique.
A dose objectives set was fixed for PTVs and OARs : for PTV1 : 95% of the PTV covered by 97% of the prescribed dose, and less than 5 % of the PTV receiving more than 107% of the prescribed dose; PTV2: 95% of the PTV covered by 95% of the prescribed dose; Rectum: maximum dose (into 1.8 cc) < 76 Gy, V72 1 25% , V60 1 50% ; Bladder V70 1 25%, V60 1 50%; Femoral heads: V50 1 5%.
Treatment planning
For each patient, two VMAT plans were generated: one with Monaco 3.0 (CMS-Elekta Ltd, Crawley, UK) and one with Pinnacle 9.0 (Philips Medical Systems, Madison, WI).
The irradiation was delivered, using 6-MV photons with an Elekta Synergy ® machine equipped with a Cone-Beam Computed Tomography (CBCT) device (XVI ® ) and with a multi-leaf collimator (MLCi2 ® ) consisting of 40 paired leaves, each measuring 1 cm in width at the isocenter. The possible dose rate values were 25 MUs/min, 50 MUs/min, 100 MUs/min, 200
MUs/min and 400 MUs/min. For each treatment plan a single 360° arc was used.
MONACO PLANNING
For Monaco planning, the optimization constraints were established on the basis of biological cost functions (i.e. Serial or parallel complication model for OARs and Poisson cell kill function for the PTVs). The prescription template applied to all patients is given in Table 1 . The optimisation was first performed in a constrained mode, meaning that all constraints to the OARs are treated as hard constraints and all optimization criteria must be met. Conversely, the constraints to the targets are considered as objectives. The pareto mode which gives priority to PTV coverage was used secondarily to achieve the PTV coverage detailed above.
Sequencing parameters used for PTV1 and PTV2 irradiation were: 124 control points (CP) to achieve in practice 120 CP; target dose rate 300 MUs/min; minimum segment width 0.5 cm; fluence smoothing: low. 
PINNACLE PLANNING
For Pinnacle planning, inverse optimization was performed using the SmartArc algorithm (6) .
The optimization objectives were defined with physical dose points. The template is shown in Table 1 . The arc sampling parameter was fixed at 3 degrees to obtain 120 CP for the full arc. The delivery time parameter was fixed at 180 s firstly; then was eventually increased to 240 s to allow more dose modulation for the most complex cases. Final dose was computed with a collapsed cone algorithm using a dose grid resolution of 3 mm. With these parameters, the time needed for optimization and final dose calculation was about 13 min on an Intel quadruple-Core (Xeon) 2.8
GHz and 16 GB RAM platform. Time for parameters adjustment was 10 min.
Preliminary work
Although this study was performed by two institutions, an important number of constraints were set to limit the influence of the planners and planning philosophy of the two hospitals. First, a preliminary comparison study was performed on a water-equivalent cylindrical phantom with a C-Shape target surrounding a central avoidance structure (data not shown) as described by the AAPM task group 119 [7] . This preliminary work allowed to harmonize both planning methods and to verify that for a simple geometry both institutions were able to produce plans of similar quality regarding dose distribution and delivery efficiency.
Treatment plans comparisons
DOSE DISTRIBUTION
In order to limit the uncertainties on DVHs calculations between both TPS, the results were evaluated in the ARTiView 1.12 software (Aquilab, Lille, France) by comparing DVHs for targets and OARs (mean dose and doses at selected points of the DHVs). Patient-averaged DVHs were compared. In addition, several quality indexes for PTV1 and total plans were assessed: homogeneity index (HI) was calculated as (D 5% -D 95% )/D mean within the PTV; D 5% and D 95% being the dose received by 5 and 95 % of the PTV [8] ; conformity index (CI) was calculated as the ratio between the volume of the reference isodose (V 95% ) and the PTV volume (V PTV ) [9] ; healthy tissue coverage index (HCO) evaluates the percentage of reference isodose which is outside the PTV volume. HCO was calculated as [100*(1-(V PTV, 95% /V 95% ))]; V PTV, 95% was the volume of PTV covered by the reference isodose.
Statistical analysis used two-sided Wilcoxon-signed rank test, a nonparametric test, calculated with PASW Version 18.0.0 (SPSS Inc., Chicago, IL). A value of p<0.05 was considered statistically significant.
To underscore the spatial localization differences between the two TPS, a patient-averaged dose distribution was performed. To obtain the averaged dose distribution, the anatomy of all the patients was registered to a typical patient anatomy. After an initialization done by an affine registration, we used an organ-driven non-rigid registration method using the demons algorithm between the CTs and between each considered organ (prostate, bladder, rectum). The final deformation field was computed by merging the different deformation fields by weighting them according to the distance between voxels and organs [10] [11] [12] . The transformation was then applied to the dose distribution.
ROBUSTNESS
In case of daily CBCT, we assume to have a geometric accuracy better than 2 mm as mentioned in the AAPM recommendations [13] . To investigate the robustness of Monaco and Pinnacle dose distributions, an isocenter shift of 2 mm was applied on one representative prostate case in unfavorable directions for the main OARs (i.e. in anterior and posterior direction). The impact on dose distribution was judged with the quality indexes described previously for PTV2, rectum wall and bladder wall.
DELIVERY EFFICIENCY
The delivery time, MU per fraction, mean dose rate and time-average MLC aperture area were used to evaluate the VMAT delivery efficiency.
Quality assurance
In order to evaluate the dose algorithm accuracy of Monaco and Pinnacle, the consistency between calculated and delivered dose was verified for one typical plan with EBT3 radiochromic films (Ashland, Covington, USA) in a pelvis anthropomorphic phantom (CIRS, Norfolk, USA).
A dosimetric validation was then performed for all plans with the Octavius phantom (PTW, Freiburg, Germany). The dose delivery was measured using the PTW 2D-array Seven29 (PTW) ionization chamber matrix. The dose was measured in coronal and sagittal planes.
Comparisons were performed with Verisoft software (PTW). The 3D gamma method was used to compare the measured dose distributions with the calculated 3D dose distribution. The dose criterion was 3% of the local dose and the distance criterion was 3 mm. The evaluated areas were areas with doses higher than 30% of the maximum dose.
RESULTS
Dose distribution
The patient-averaged differences in the dose distributions for the two TPS are shown in Figure 1 .
Large differences are observed. First, Monaco favoured the dose delivery on gantry angles that allowed crossing a minimum volume of healthy tissue to reach the PTV. Therefore, the volume of healthy tissue receiving higher doses was more important with Pinnacle than with Monaco. Table 2 as averages for the investigated patients. Figure 2 shows that Pinnacle plans resulted in more dose into the PTVs than Monaco but with a more important scattering. While the mean dose to PTV1 was significantly different between both modalities (p=0.008), the difference was not statistically significant on PTV2 (p=0.241) ( Table 2) . 
Treatment delivery evaluation
Details of efficiency parameters are shown in Table 4 ; Figure 3 shows the variations of MLC aperture area and dose rate as a function of gantry angle during typical VMAT delivery. Monaco plans needed one and a half more MUs than Pinnacle plans. Nevertheless we noticed similar delivery times because the time-averaged dose rates were higher with Monaco (230 MUs/min) than with Pinnacle (160 MUs/min).
The better efficiency of Pinnacle plans was due to a larger MLC aperture area ( Fig. 3 , Table 4 ).
On average, total MUs to MLC aperture area ratio was 265 MUs/cm² for Monaco plans and 110 MUs/cm² for Pinnacle plans.
The variation of the area according to the gantry angle ( Fig. 3) shows that the segmentation is based on an alternative Sliding Window pattern for Monaco VMAT (i.e. all the leaves moves first on one way and then on the other way alternatively for the full arc) .
Quality assurance
The analysis of the films placed inside an anthropomorphic phantom showed that 99.1% and 98.4% of the points passed the 3%/3 mm criterion with mean gamma values of 0.34 and 0.31 for Monaco and Pinnacle respectively. Central area encompassing the PTV showed high consistency between calculated and delivered dose for Pinnacle and Monaco; the mean gamma values were 0.29 for both TPS.
The results obtained with the 2D matrix ionisation chamber showed a high passing rate (> 97.4%) for the gamma index for both TPS (Table 4 ). Nevertheless, Monaco provided better dosimetric agreement than Pinnacle. To explain the QA results differences, we investigated the dosegradient values [14] in the two measurement plans of the Octavius phantom (Table 4 ). For coronal planes, mean dose-gradients were similar for both TPS but maximum dose-gradient was higher with Pinnacle. For sagittal planes, all reported dose-gradient values were higher with Pinnacle.
DISCUSSION
The aim of the present study was to investigate the performances of Monaco and Pinnacle TPS for VMAT plan optimization. To our knowledge, this is the first study yielding a global comparison of two TPS for VMAT planning, from the prescription phase and dose distribution evaluation to the delivery efficiency. We also included beam geometry, treatment delivery parameters and quality control results.
For prostate cancer, VMAT solutions proposed by both TPS offered good PTV coverage and
OARs sparing, with similar delivery time. Note that the lowest doses to the OARs were achieved with Monaco, except for the rectal wall. Regarding dose distribution and delivery parameters large differences were observed. First on dose distribution, we noticed that Monaco favoured the dose delivery from gantry angles that allowed crossing a minimum volume of healthy tissue to reach the PTV. As a consequence, much lower doses were delivered to the FH in comparison with Pinnacle, despite the fact that contrarily to Pinnacle, no constraint was assigned to the FH on Monaco prescription. Likewise, healthy tissue contained in the CT area received less dose with Monaco than with Pinnacle. However, this result must be taken with care since the uncertainties in TPS dose calculation are generally larger in the lower dose regions. Indeed, the uncertainty in Monte Carlo calculation is influenced by the variance reduction techniques and inversely proportional to the square root of the number of histories used for dose calculation. The uncertainty of the entire plan is always less than the variance value for dose calculation since that value is per segment (i.e. 3 % in our case, for Monaco TPS). Therefore the noise which can be observed is substantially reduced in high dose area where a more important number of segments contribute to the dose (superposition effect) [15] . Furthermore, it is well known that the main part of out-of-field doses are due to the linac-head scatter and leakage radiation, proportional to MUs [16;17] . In this case Monaco could provide a higher out-of-field dose. Hence, both TPS provide different irradiation patterns regarding low doses without superiority of one TPS was clearly demonstrated.
Finally, higher doses were delivered in the antero-posterior direction, above the bladder or below the rectum with Monaco compared to Pinnacle. Therefore, with Monaco TPS, an anatomical deformation of the rectum or bladder will probably have more consequences on the delivered dose to these organs. In particular, it has been shown that the relative volume of the rectum can vary by more than 150% from one day to another [18] . Thus in this case, the risk of rectal toxicity is increased and it is of importance to make a daily imaging control. The robustness investigation of dose distributions showed that the impact of 2 mm isocentre shifts provided very low and similar dose deviations for Monaco and Pinnacle plans : Table 3 showed that the dose deviations were always less than 5% of the prescribed dose and the dose deviations differences were less than 1% of the prescribed dose between the both TPS. Therefore both TPS provided robust plans. In practice, it is possible to get the same results using physical or biological cost functions even though physical cost functions are not as easy to control since one constraint only controls one dose point. Therefore one single biological cost function will always lead to a better dosimetric solution than one single physical cost function, but is this true for one biological cost function against 3 physical cost functions? There will always be a high proportion of subjectivity concerning all the studies performed on this subject since the results highly depend: 1/ on the planner and his degree of experience with either physical or biological cost functions 2/ on how many physical and biological cost functions are used in the prescription The above papers did not give any details about the prescription templates the authors used to get their results. In the present study, the planners had to use the prescription template that they had found to be best suitable for treating prostate cancer. Monaco planner chose to combine biological and physical cost functions, since from their practices, the best results were obtained with mixed prescriptions, whereas Pinnacle planner preferred physical cost functions, since they did not get better results with biological prescriptions.
Regarding the treatment delivery efficiency, the treatment control system of the Elekta accelerator adjusts the dose rate, the gantry and leaves speeds to offer the lowest delivery time possible for VMAT plans. This adjustment is efficient since despite different numbers of MUs, Monaco and Pinnacle plans were delivered with similar times. We noticed this adjustment particularly with the dose rate variation; Monaco plans were delivered with time-average dose rate 44% higher than Pinnacle plans. Previous studies compared VMAT performed with Monaco or other TPS [3;4] . Similarly to our results they found that Monaco provided more MUs than other TPS.
Concerning QA analysis, many precautions have been taken. First, to limit the impact of the beam-modeling, one set of beam data was used for the commissioning of both TPS [15;21] .
Previous QA results showed that TPS commissioning are consistent for Monaco and Pinnacle.
We found similar dosimetric agreement for static fields for both TPS: for 3×3 cm² and 20×20 cm² field sizes the mean gamma values were 0.208 and 0.238, and 0.163 and 0.265 in a homogeneous phantom for Monaco and Pinnacle, respectively.
Then to avoid uncertainties with QA implementation, the same operator performed the measurements simultaneously for both TPS on the linear accelerator. Our results demonstrated a high passing rate for VMAT plan QA for both TPS. Nevertheless, Monaco provided better dosimetric agreement than Pinnacle. However, the lowest dosimetric agreement results were obtained for the planes where the highest dose-gradients were observed (i.e. sagittal Pinnacle planes).
In addition to this data , film analysis in an anthropomorphic phantom showed that for both TPS more than 98 % of points passed the (3%, 3 mm) gamma index criterion. Therefore, the dose algorithm accuracy of both TPS was verified in inhomogeneous conditions for pelvis cases thus proving that that there is no advantage to use Monaco at the expense of Pinnacle regarding to dosimetric accuracy for the studied case.
CONCLUSION
For prostate cancer patients, VMAT planned with Monaco and Pinnacle TPS offered clinically acceptable dose distributions. Monaco plans showed enhanced OAR sparing but lower doses into the PTV compared to Pinnacle plans. Similar delivery times were found for both TPS but Pinnacle solution required less MUs. Finally, a good dosimetric agreement with measured doses was achieved with both TPS, but Monaco offered a slightly higher passing rate in the gamma index analysis. Further investigations are in progress to confirm the performances of both TPS on more complex volumes (head and neck cancer or prostate with pelvic node involvement). 
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